Home-Based Tele-Exercise vs. Hospital-Based Exercise Programs in Patients With Prediabetes

NCT06895161 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 42

Last updated 2026-04-09

No results posted yet for this study

Summary

This study aims to compare the effects of tele-exercise(TELE) and hospital-based exercise(HBE) on functional capacity (maximum oxygen consumption), glycemic control, quality of life and sleep quality in individuals with prediabetes. Aerobic exercise will be performed 5 days a week for 30 minutes with moderate intensity continuous walking for a total of 3 weeks.While the HBE group will the exercise program under supervision in hospital,the TELE group wil perform the exercise program at home/outdoors using Polar H9 heart rate monitor. The control group (CON) will perform the exercise program at home/outdoors without any monitoring or follow up.

Conditions

  • Prediabetes
  • Prediabetes (Insulin Resistance, Impaired Glucose Tolerance)
  • Telemedecine

Interventions

OTHER

Remotely supervised exercise at home or outdoors

Aerobic exercise at home/outdoors 30 minutes each session,five days a week for three weeks using a Polar H9 heart rate monitor.

OTHER

Hospital-based exercise program

The aerobic exercise ,30 minutes each session,five days a week for three weeks at cardiopulmonary rehabilitation unit under supervision.

OTHER

Phone calls with reinforcement feedback

Calls twice a week that include symptom inquiries and encouraging feedback on exercise

Sponsors & Collaborators

  • Gazi University

    lead OTHER

Principal Investigators

  • Çise C Güngör, MD · Gazi University Faculty of Medicine

  • Nesrin Ü Demirsoy, MD · Gazi University Faculty of Medicine

  • Levent Karataş, MD · Gazi University Faculty of Medicine

  • Muhittin M Yalçın, MD · Gazi University Faculty of Medicine

  • Levent A Güngör, MD · Gazi University Faculty of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
79 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-01
Primary Completion
2025-12-15
Completion
2025-12-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06895161 on ClinicalTrials.gov